ORIGINAL RESEARCH article

Front. Cardiovasc. Med.

Sec. Hypertension

Volume 12 - 2025 | doi: 10.3389/fcvm.2025.1521087

This article is part of the Research TopicEmerging Molecules in Pulmonary Hypertension: Diagnosis, Risk Prediction, Treatment and PrognosisView all 4 articles

Identification of a PANoptosis-Related Gene Signature Reveals Therapeutic Potential of SFRP2 in Pulmonary Arterial Hypertension

Provisionally accepted
  • Changsha Fourth Hospital, Changsha, China

The final, formatted version of the article will be published soon.

Background: Pulmonary arterial hypertension (PAH) is a serious condition marked by elevated pulmonary artery pressure, often progressing to right heart failure and high mortality. PANoptosis, an inflammatory form of programmed cell death, remains understudied in the context of PAH. This study aims to identify and validate PANoptosis-related signature genes in PAH using bioinformatics analysis alongside in vivo and in vitro experiments, seeking to uncover its potential role in disease progression.

Keywords: PANoptosis, pulmonary arterial hypertension, bioinformatics, sFRP2, Immune Cell Infiltration

Received: 01 Nov 2024; Accepted: 17 Apr 2025.

Copyright: © 2025 Li and Jurat. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Mirkamil Jurat, Changsha Fourth Hospital, Changsha, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.